Autoimmune associated congenital heart block: Integration of clinical and research clues in the management of the maternal/foetal dyad at risk

Journal of Internal Medicine

Volumn 265, Issue 6, 2009, Pages 653-662

  Buyon, J P ^a   Clancy, R M ^a   Friedman, D M ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Anti Ro La antibodies; Congenital heart block; PR interval

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; IMMUNOGLOBULIN; LA ANTIBODY; RO ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; CELL INTERACTION; CLINICAL TRIAL; CONFERENCE PAPER; CONGENITAL HEART BLOCK; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; FETUS RISK; HEART MUSCLE FIBROSIS; HUMAN; MACROPHAGE; MATERNAL CARE; MYOFIBROBLAST; PATHOGENESIS; PR INTERVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; FETAL HEART; GESTATIONAL AGE; HEART BLOCK; HUMANS; MALE; PREGNANCY; RISK FACTORS; TIME FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 66149127020     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02100.x     Document Type: Conference Paper

References (37)

1. Buyon JP, Clancy RM. Neonatal lupus. In : Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. Philadelphia, PA : Lippincott Williams & Wilkins, 2006 1058 80.
2. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 1996 157 : 3317 22. (Pubitemid 126449142)
3. Lee LA. Neonatal lupus erythematosus. J Invest Dermatol 1993 100 : 9S 13S. (Pubitemid 23035886)
4. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998 31 : 1658 66. (Pubitemid 28273312)
5. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994 120 : 544 51. (Pubitemid 24091594)
6. Silverman ED. Congenital heart block and neonatal lupus erythematosus: prevention is the goal. J Rheumatol 1993 20 : 1101 4. (Pubitemid 23278156)
7. Julkunen H, Kurki P, Kaaja R et al. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A-Ro and to SS-B-La. Arthritis Rheum 1993 36 : 1588 98. (Pubitemid 23327758)
8. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991 17 : 1360 6.
9. Moak JP, Barron KS, Hougen TJ et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001 37 : 238 42. (Pubitemid 32051745)
10. Askanase AD, Friedman DM, Copel J et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA-Ro-SSB-La antibodies. Lupus 2002 11 : 145 51. (Pubitemid 34296929)
11. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage-fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004 50 : 173 82. (Pubitemid 38084302)
12. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999 42 : 2335 45. (Pubitemid 30333414)
13. Buyon J. Neonatal lupus syndromes. In : Lahita R, ed. Systemic Lupus Erythematosus. San Diego, CA : Academic Press, 1999 : 337.
14. Ottosson L, Hennig J, Espinosa A, Brauner S, Wahren-Herlenius M, Sunnerhagen M. Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjogren's syndrome. Mol Immunol 2006 43 : 588 98. (Pubitemid 41785386)
15. Ottosson L, Salomonsson S, Hennig J et al. Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein. Scand J Immunol 2005 61 : 109 18. (Pubitemid 40255354)
16. Buyon JP, Slade SG, Reveille JD, Hamel JC, Chan EK. Autoantibody responses to the "native" 52-kDa SS-A-Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome. J Immunol 1994 152 : 3675 84. (Pubitemid 24098066)
17. Clancy RM, Buyon JP, Ikeda K et al. Maternal antibody responses to the 52-kd SSA-RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum 2005 52 : 3079 86. (Pubitemid 41447089)
18. Ambrosi A, Strandberg L, Ottosson L, Kampe O, Wahren-Herlenius M. Anti-Ro52 antibodies inducing heart block cross-react with alpha-enolase. Arthritis Rheum 2007 56 : S783.
19. Llanos C, Chan E, Li S et al. Antibody reactivity to alpha-enolase in mothers of children with Congenital Heart Block. J Rheumatol 2008 36 : 565 9.
20. Boutjdir M, Chen L, Zhang ZH, Tseng CE, El-Sherif N, Buyon JP. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr Res 1998 44 : 11 9. (Pubitemid 28303438)
21. Mazel JA, El-Sherif N, Buyon J, Boutjdir M. Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 1999 99 : 1914 8. (Pubitemid 29181423)
22. Qu Y, Xiao GQ, Chen L, Boutjdir M. Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels. J Mol Cell Cardiol 2001 33 : 1153 63. (Pubitemid 32579282)
23. Buyon JP, Clancy R, Di Donato F et al. Cardiac 5-HT(4) serotoninergic receptors, 52kD SSA-Ro and autoimmune-associated congenital heart block. J Autoimmun 2002 19 : 79 86. (Pubitemid 35205203)
24. Clancy RM, Backer CB, Yin X, Kapur RP, Molad Y, Buyon JP. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003 171 : 3253 61. (Pubitemid 37093552)
25. Clancy RM, Neufing PJ, Zheng P et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA-Ro and -SSB-La antibodies in the pathogenesis of congenital heart block. J Clin Invest 2006 116 : 2413 22. (Pubitemid 44330140)
26. Miranda-Carus ME, Askanase AD, Clancy RM et al. Anti-SSA-Ro and anti-SSB-La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 2000 165 : 5345 51.
27. Clancy RM, Askanase AD, Kapur RP et al. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA-Ro-SSB-La antibody-mediated congenital heart block. J Immunol 2002 169 : 2156 63.
28. Clancy R, Izmirly P, Kimberly RP et al. Coercion of innate immunity to amplify the adaptive immune response in the cascade to cardiac injury in CHB: implications for prevention with antimalarials. Arthritis Rheum 2007 56 : S810.
29. Clancy RM, Zheng P, O'Mahony M et al. Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block. Arthritis Rheum 2007 56 : 4120 31. (Pubitemid 350262340)
30. McCue CM, Mantakas ME, Tingelstad JB, Ruddy S. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977 56 : 82 90. (Pubitemid 8137684)
31. Geggel RL, Tucker L, Szer I. Postnatal progression from second- to third-degree heart block in neonatal lupus syndrome. J Pediatr 1988 113 : 1049 52. (Pubitemid 19014258)
32. Friedman DM, Kim MY, Copel JA et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 2008 117 : 485 93.
33. Kaaja R, Julkunen H. Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. Arthritis Rheum 2003 48 : 280 1 author reply 1-2.
34. Looney RJ, Huggins J. Use of intravenous immunoglobulin G (IVIG). Best Pract Res Clin Haematol 2006 19 : 3 25. (Pubitemid 43118860)
35. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001 291 : 484 6. (Pubitemid 32097072)
36. Nimmerjahn F, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 2008 26 : 513 33.
37. Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 2007 26 : 513 33. (Pubitemid 46148750)